CLINICAL USE OF BETA-ADRENOCEPTOR BLOCKADE IN SYSTEMIC HYPERTENSION

β-Blockers are effective in reducing the blood pressure of many patients with systemic hypertension. They differ in terms of the presence or absence of intrinsic sympathomimetic activity, membrane-stabilising activity, β1-selectivity, α-blocking properties, and relative potency and duration of action. All β-blockers appear to have blood pressure lowering effects. The choice of which β-blocker to use in an individual patient is determined by the pharmacodynamic and pharmacokinetic differences between the drugs in conjunction with the patient’s other medical condition(s). This review discusses the practical use of β-blockers and provides rational suggestions for which drug(s) to use in selected patient groups (Black, elderly, postinfarction, diabetes, renal disease, obstructive lung disease, elevated lipid levels, coexisting angina, and left ventricular hypertrophy). © 1990, ADIS Press Limited. All rights reserved.